Private medical detox for Miami — 65 minutes, then straight into treatment.

For clients in Miami, RECO Island's Delray Beach campus is 50 miles north — about 65 minutes up I-95 from Brickell and a little longer from Coral Gables or Pinecrest. Detox and residential run under one clinical team on the same campus, so the transition out of withdrawal happens the same day the residential treatment plan begins, without a chart transfer or a return trip through Miami-Dade traffic. Symptom-triggered CIWA-Ar and COWS protocols are run by trained nursing at bedside; physician coverage is 24/7 and every admission includes a full medical evaluation on day one.

The drive from Brickell or Coral Gables up I-95 to RECO Island’s Delray Beach campus runs about 50 miles and roughly 65 minutes in typical traffic. For most clients in Miami, that distance is part of the clinical rationale — physical separation from the bars, dealers, and social circuits tied to active use is a therapeutic variable, and medical detox at RECO Island is structured as a residential admission rather than a daily commute. What follows is a physician-led, nurse-staffed detoxification stay that transitions directly into residential care under the same clinical team.

When medical detox is the clinical indication

Medical detox is not required for every substance use disorder and is not the right entry point for every presentation. It is indicated when withdrawal risk crosses from uncomfortable into medically dangerous — alcohol use disorder with regular heavy consumption, benzodiazepine dependence at therapeutic or supratherapeutic doses, opioid use disorder with daily use of short-acting opioids, and polysubstance patterns that combine any of the above. Alcohol and benzodiazepine withdrawal in particular carry seizure and delirium risk; unmanaged, both can be fatal.

The level-of-care decision at intake is structured, not arbitrary. ASAM Criteria organizes it across six dimensions: acute intoxication and withdrawal potential, biomedical conditions, emotional and behavioral conditions, readiness to change, relapse potential, and recovery environment. A client presenting from a Brickell high-rise with a stable job and a prior taper attempt scores differently on the environment dimension than a client whose living situation actively reinforces use, and both scores affect whether outpatient detox, residential detox, or a hospital-based ASAM 4-WM setting is the appropriate entry point.

Stimulant-only detox is a separate question. Cocaine and methamphetamine withdrawal is not usually medically dangerous, but the acute crash — anhedonia, hypersomnia, dysphoria, suicidal ideation — has clinical significance and is safer supported in a monitored setting. Where a client presents with primary stimulant use, the admission conversation focuses on co-occurring depression, sleep architecture, and relapse triggers rather than seizure prophylaxis.

Symptom-triggered protocols using validated withdrawal scales

Alcohol withdrawal is managed with symptom-triggered benzodiazepine dosing driven by CIWA-Ar scores rather than a fixed taper. CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, revised) rates ten symptom domains — nausea, tremor, paroxysmal sweats, anxiety, agitation, tactile, auditory, and visual disturbances, headache, and orientation — at defined intervals, typically every one to four hours in the acute phase. Medication (usually lorazepam or chlordiazepoxide) is administered when the score crosses treatment threshold; below threshold, the client is reassessed rather than dosed. Symptom-triggered protocols reduce total benzodiazepine exposure and shorten the detox course compared with fixed-schedule regimens.

Opioid withdrawal is scored on COWS (Clinical Opiate Withdrawal Scale), which rates eleven signs and symptoms including resting pulse rate, GI upset, tremor, yawning, and pupil size. Induction onto buprenorphine or buprenorphine-naloxone is initiated once the COWS score confirms sufficient withdrawal to avoid precipitated withdrawal — typically a score of 12 or higher — and dosing is titrated against symptom response. For clients who are candidates for extended-release naltrexone rather than buprenorphine maintenance, the pathway looks different: full clearance of opioids, verified by urine drug screen, followed by a naltrexone challenge before the depot injection.

Symptom-triggered protocols are standard of care in the addiction medicine literature. They require trained nursing running scales at bedside and a clinical culture that treats a low score as valid data rather than a reason to medicate anyway. This is the practical difference between a competent detox and a nominal one.

Medical evaluation and comorbidity management

Every admission includes a full medical evaluation on day one — history, physical, and standard labs (CBC, CMP, LFTs, TSH, magnesium, urine drug screen, urine pregnancy screen where indicated, and EKG where cardiovascular risk or QTc-prolonging medications warrant). Vitamin repletion — thiamine, folate, multivitamin — is initiated in every alcohol admission on the first evaluation, not after a Wernicke’s presentation.

Chronic medical conditions are managed concurrently with withdrawal, not deferred. Hypertension, type 2 diabetes, hepatitis C, chronic pain syndromes, and cardiovascular disease all interact with detox pharmacology and with the physiologic stress of withdrawal itself. Medication reconciliation on admission identifies contraindications and interactions — for example, quetiapine is frequently present on the pre-admission medication list and requires QTc monitoring during acute alcohol withdrawal when combined with ondansetron or other QT-prolonging agents.

Co-occurring psychiatric conditions are assessed but generally not medicated for the first time during acute detox. PHQ-9 and GAD-7 scores collected on day one are re-collected in the residential phase, because depression and anxiety scores at the peak of withdrawal are not clinically meaningful — they will improve as withdrawal resolves. New antidepressant, mood stabilizer, or antipsychotic starts (sertraline, lithium, aripiprazole) are typically deferred until the residential baseline is visible.

The transition into residential care without gaps

The most consequential moment in any detox stay is the day the client transitions out. In fragmented systems, that day is where treatment episodes fail — the detox facility discharges, a residential bed is not open, the client returns to Miami for a “few days,” and readmission never happens.

RECO Island’s model removes that gap by design. Detox and residential are the same organization on the same campus. The transition into residential is scheduled at admission, not negotiated on day five. The primary therapist assigned during detox stays with the client through residential and, in most cases, into partial hospitalization. There is no chart transfer, no re-intake, no re-explaining the trauma history to a new clinician. Modalities used across levels of care — CBT, DBT skills training, motivational interviewing, EMDR for trauma, ACT for values-based work — are documented once and continue without interruption.

For a Miami client, this matters materially. Traveling back to Aventura or Coconut Grove on day six to bridge to another facility means driving past the environments that produced the presentation. Same-campus transition removes that transit entirely.

What to expect on the first day

Admission from Miami typically begins with a phone screen — a 20 to 30 minute clinical conversation covering substance use history, medical history, current medications, and insurance verification. Where CIWA-Ar or COWS risk is meaningful, admission is expedited to same-day or next-day. Transport from Miami-Dade can be arranged; most clients are driven up I-95 by a family member.

On arrival, the client is met by admissions and a nurse. Vitals, medical evaluation, labs, and initial CIWA-Ar or COWS scoring are completed within the first two hours. Medication for acute withdrawal is initiated based on that first assessment, and — where appropriate — the first sleep in several days generally follows.

Insurance and admissions from Miami

RECO Island’s admissions team verifies benefits for most major commercial plans held by Florida employers and marketplace enrollees, including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and Blue Cross Blue Shield. Verification covers the specific detox and residential benefit tiers on the client’s plan, any prior-authorization requirement, and the deductible and out-of-pocket position for the calendar year. Out-of-network benefits are frequently workable for the commercial plans held by Miami employers; self-pay pricing and single-case agreements are handled directly by admissions.

Serving residents of: Brickell, Coral Gables, Coconut Grove, Aventura, Pinecrest.